Improved systemic ventricular function after carvedilol administration in a patient with congenitally corrected transposition of the great arteries

Journal of Heart and Lung Transplantation

Volumn 22, Issue 2, 2003, Pages 198-201

  Lindenfeld, JoAnn ^a,c   Keller, Karin ^a   Campbell, David N ^b   Wolfe, Robert R ^a   Quaife, Robert A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL; DIGOXIN; ENALAPRIL; FUROSEMIDE; POTASSIUM CHLORIDE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GREAT VESSELS TRANSPOSITION; HEART OUTPUT; HEART TRANSPLANTATION; HEART VENTRICLE FUNCTION; HUMAN; LUNG EDEMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PULMONARY VALVE STENOSIS;

ADRENERGIC BETA-ANTAGONISTS; CARBAZOLES; HUMANS; MALE; MIDDLE AGED; PROPANOLAMINES; STROKE VOLUME; TRANSPOSITION OF GREAT VESSELS; VENTRICULAR DYSFUNCTION;

EID: 0037312007     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00656-3     Document Type: Article

References (21)

1. Voskuil M., Hazecamp M.G., Kroft L.J.M., et al. Post-surgical course of patients with congenitally corrected transposition of the great arteries. Am J Cardiol. 83:1999;558-562.
2. Graham T.P. Jr, Bernard Y.D., Mellen B.G., et al. Long-term outcome in congenitally corrected transposition of the great arteries. J Am Coll Cardiol. 36:2000;255-261.
3. Hornung T.S., Bernard E.J., Celermajer D.S., et al. Right ventricular dysfunction in congenitally corrected transposition of the great arteries. Am J Cardiol. 84:1999;1116-1119.
4. Dimas A.P., Moodie D.S., Sterba R., et al. Long-term function of the morphologic right ventricle in adult patients with corrected transposition of the great arteries. Am Heart J. 118:1989;526-530.
5. Ikeda U., Furuse M., Suzuki O., et al. Long term survival in aged patients with corrected transposition of the great arteries. Chest. 101:1992;1382-1385.
6. Presbitero P., Somerille J., Rabajoli F., et al. Corrected transposition of the great arteries without associated defects in adult patients clinical profile and follow-up. Br Heart J. 74:1995;57-59.
7. Melero-Pita A., Alfonso-Pardo F., Bardaji-Mayor J.L., et al. Corrected transposition of the great arteries. N Engl J Med. 334:1996;866-867.
8. Graham T.P. Jr, Parrish M.D., Boucek R.J. Jr, et al. Assessment of ventricular size and function in congenitally corrected transposition of the great arteries. Am J Cardiolvol. 51:1983;244-251.
9. Sano T., Riesenfeld T., Karl T.R., et al. Intermediate-term outcome after intracardiac repair of associated cardiac defects in patients with atrioventricular and ventriculoarterial discordance. Circulation. 92:(supplII):1995;II-272-278.
10. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) a randomized trial. Lancet. 353:1999;9-13.
11. Packer M., Coats A.J., Fowler M.B., et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 344:2001;1651-1658.
12. Effect of metoprolol CR/XL in chronic heart failure Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 353:1999;2001-2007.
13. Connelly M.S., Liu P.P., Williams W.G., et al. Congenitally corrected transposition of the great arteries in the adult functional status and complications. J Am Coll Cardiol. 27:1996;1238-1243.
14. Perloff J.K. Normal myocardial growth and the development and regression of increased ventricular mass. Perloff J.K., Child J.S. Congenital heart disease in adults. 2nd ed:1998;357-366 W.B. Saunders, Philadelphia.
15. Singh T.P., Wolfe R.R., Sullivan N.M., et al. Assessment of progressive changes in exercise performance in patients with a systemic right ventricle following the atrial switch repair. Pediatr Cardiol. 22:2001;210-214.
16. Hall S.A., Cigarroa C.G., Marcoux L., et al. Time course of improvement in left ventricular function, mass and geometry in patient with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol. 25:1995;1154-1161.
17. Lowes B.D., Gill E.A., Abraham W.T., et al. Effects of carvedilol on left ventricular mass, chamber geometry and mitral regurgitation in chronic heart failure. Am J Cardiol. 83:1999;1201-1205.
18. Clark B.J. Treatment of heart failure in infants and children. Heart Dis. 2:2000;354-361.
19. Kay J.D., Colan S.D., Graham T.P. Jr. Congestive heart failure in pediatric patients. Am Heart J. 142:2001;923-928.
20. Bruns L.A., Chrisant M.K., Lamour J.M., et al. Carvedilol as therapy in pediatric heart failure an initial multicenter experience. J Pediatr. 138:2001;505-511.
21. Buchhorn R., Hulpke-Wette M., Hilgers R., et al. Propranolol treatment of congestive heart failure in infants with congenital heart disease the CHF-PRO-INFANT Trial. Int J Cardiol. 79:2001;167-173.